UPM Pharmaceuticals has successfully serialized its first product in May. The company anticipates having all of its clients’ products serialized by the November 2017 deadline in accordance with the Drug Supply Chain Security Act, which mandates that pharmaceutical manufacturers serialize all pharmaceutical products starting in November 2017.  
 
UPM chose Laetus as its serialization hardware platform. Lateus provides the development and production of inspection solutions to ensure serialization accuracy and product quality. UPM is using TraceLink as their code provider. TraceLink is a Track and Trace Network for connecting the supply chain and eliminating counterfeiting of prescription medication around the world.
 
Jim Gregory, chief executive officer of UPM Pharmaceuticals, said, “While we know the FDA recently granted a one year extension on their serialization deadline, we are very excited about our early implementation and success with serialization.  Using the Lateus system provides 100% verification of the data matrix code against the human readable text.  This insures products leaving the UPM facility are fully compliant and traceable. Lateus equipment also allowed us flexibility in that everything is printed in our label office and can be printed in advance.  This saves time and the client money.”